Trident cold atmospheric plasma blocks three cancer survival pathways to overcome therapy resistance
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Trident cold atmospheric plasma blocks three cancer survival pathways to overcome therapy resistance
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 118, Issue 51, Pages e2107220118
Publisher
Proceedings of the National Academy of Sciences
Online
2021-12-17
DOI
10.1073/pnas.2107220118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Femoral Heads from Total Hip Arthroplasty as a Source of Adult Hematopoietic Cells
- (2021) Anthony D. Pomicter et al. ACTA HAEMATOLOGICA
- Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity
- (2021) Ke Xu et al. SCIENCE
- Successful Treatment of Vitiligo with Cold Atmospheric Plasma‒Activated Hydrogel
- (2021) Siyue Zhai et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Transdermal cold atmospheric plasma-mediated immune checkpoint blockade therapy
- (2020) Guojun Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- xCT (SLC7A11) expression confers intrinsic resistance to physical plasma treatment in tumor cells
- (2020) Sander Bekeschus et al. Redox Biology
- Influence of Cell Type and Culture Medium on Determining Cancer Selectivity of Cold Atmospheric Plasma Treatment
- (2019) Biscop et al. Cancers
- Genetic code expansion and live cell imaging reveal that Thr-308 phosphorylation is irreplaceable and sufficient for Akt1 activity
- (2018) Nileeka Balasuriya et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies
- (2018) Maria Apicella et al. Cell Metabolism
- Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study
- (2018) Elias Jabbour et al. Lancet Haematology
- Tyrosine kinase inhibitor combination therapy in first-line treatment of non-small-cell lung cancer: systematic review and network meta-analysis
- (2017) Sarah Batson et al. OncoTargets and Therapy
- Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT
- (2016) P Tsirigotis et al. BONE MARROW TRANSPLANTATION
- Non-Thermal Plasma in Contact with Water: The Origin of Species
- (2016) Yury Gorbanev et al. CHEMISTRY-A EUROPEAN JOURNAL
- The Protective Roles of ROS-Mediated Mitophagy on125I Seeds Radiation Induced Cell Death in HCT116 Cells
- (2016) Lelin Hu et al. Oxidative Medicine and Cellular Longevity
- Targeting Lactate Dehydrogenase-A Inhibits Tumorigenesis and Tumor Progression in Mouse Models of Lung Cancer and Impacts Tumor-Initiating Cells
- (2014) Han Xie et al. Cell Metabolism
- Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma
- (2014) Georgina V. Long et al. Nature Communications
- Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with nilotinib against BCR-ABL-positive leukemia cells involves the ABL kinase domain mutation
- (2013) Seiichi Okabe et al. CANCER BIOLOGY & THERAPY
- BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships
- (2012) J. S. Khorashad et al. BLOOD
- Effects of Bone-Targeted Agents on Cancer Progression and Mortality
- (2012) R. Coleman et al. JNCI-Journal of the National Cancer Institute
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
- (2012) Gregg L. Semenza TRENDS IN PHARMACOLOGICAL SCIENCES
- Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer
- (2011) E E Vincent et al. BRITISH JOURNAL OF CANCER
- Mutant BRAF Melanomas—Dependence and Resistance
- (2011) Poulikos I. Poulikakos et al. CANCER CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Quantitative comparison of surgical margin histology following excision with traditional electrosurgery and a low-thermal-injury dissection device
- (2011) Manuel E. Ruidiaz et al. JOURNAL OF SURGICAL ONCOLOGY
- Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells
- (2011) A Silva et al. LEUKEMIA
- Plasma-Induced Death of HepG2 Cancer Cells: Intracellular Effects of Reactive Species
- (2011) Xu Yan et al. Plasma Processes and Polymers
- Aerobic Glycolysis Suppresses p53 Activity to Provide Selective Protection from Apoptosis upon Loss of Growth Signals or Inhibition of BCR-Abl
- (2010) E. F. Mason et al. CANCER RESEARCH
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1α-induced metabolic reprograming
- (2010) F Zhao et al. ONCOGENE
- Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
- (2010) A. Le et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
- (2009) Thomas O'Hare et al. CANCER CELL
- Abnormalities in Glucose Uptake and Metabolism in Imatinib-Resistant Human BCR-ABL-Positive Cells
- (2009) D. J. Kominsky et al. CLINICAL CANCER RESEARCH
- Association of reactive oxygen species levels and radioresistance in cancer stem cells
- (2009) Maximilian Diehn et al. NATURE
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- Plasma medicine: an introductory review
- (2009) M G Kong et al. NEW JOURNAL OF PHYSICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started